Impel Pharmaceuticals Inc. (IMPL) NASDAQ

$8.70 -0.02 (-0.23%)

Market Cap: $201.62M

As of 08/12/22 04:00 PM EDT. Market closed.

(IMPL)

Impel Pharmaceuticals Inc. (IMPL) NASDAQ

$8.70 -0.02 (-0.23%)

Market Cap: $201.62M

As of 08/12/22 04:00 PM EDT. Market closed.

Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory ... read more

Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory Delivery (POD®) system with well-established therapeutics, including TRUDHESA™ for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Michael Hite
Full Time Employees
59
URL
Address
201 ELLIOTT AVE. W, SUITE 260, Washington, Seattle, 98119.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Michael Hite
Full Time Employees
59
Address
201 ELLIOTT AVE. W, SUITE 260, Washington, Seattle, 98119.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$8.66
Previous Close
$8.72
Days Range
$8.55 - $8.90
52 week range
$5.72 - $34.75
Volume
25,840
Avg. Volume (30 days)
29,343
Market Cap
$201.62M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
23,175,242
Open
$8.66
Previous Close
$8.72
Days Range
$8.55 - $8.90
52 week range
$5.72 - $34.75
Volume
25,840
Avg. Volume (30 days)
29,343
Market Cap
$201.62M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
23,175,242

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IMPEL PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
SHREWSBURY STEPHEN B Chief Medical Officer Mar 29, 2022 Option Exercise $1.97 24,606 48,474 97,990 Mar 30, 2022, 09:54 PM
Hoekman John Chief Scientific Officer Dec 22, 2021 Option Exercise $1.64 20,000 32,800 128,221 Dec 23, 2021, 04:50 PM
NELSON TIMOTHY S Director Nov 19, 2021 Buy $10.76 10,000 107,554 10,000 Nov 22, 2021, 05:05 PM
SHREWSBURY STEPHEN B Chief Medical Officer Sep 21, 2021 Option Exercise $2.72 73,384 199,720 73,384 Sep 22, 2021, 04:57 PM
ADAMS ADRIAN COB, CEO and President Aug 18, 2021 Buy $13.99 20,000 279,790 20,000 Aug 19, 2021, 05:23 PM
Vivo Capital VIII, LLC 10% Owner Apr 27, 2021 Option Exercise $13.50 101,456 1,369,656 2,029,495 Apr 29, 2021, 09:10 PM
Vivo Capital VIII, LLC 10% Owner Apr 27, 2021 Buy $15.00 575,000 8,625,000 2,535,115 Apr 29, 2021, 09:10 PM
venBio Global Strategic Fund II L.P. 10% Owner Apr 27, 2021 Buy $15.00 450,000 6,750,000 2,759,791 Apr 29, 2021, 06:44 PM
PARKER H STEWART Director Apr 27, 2021 Option Exercise $13.50 271 3,659 18,027 Apr 29, 2021, 06:33 PM
KKR Iris Investors LLC 10% Owner Apr 27, 2021 Option Exercise $13.50 118,712 1,602,612 2,702,638 Apr 29, 2021, 05:07 PM
KKR Iris Investors LLC 10% Owner Apr 27, 2021 Buy $15.00 1,100,000 16,500,000 3,802,638 Apr 29, 2021, 05:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
SHREWSBURY STEPHEN B Chief Medical Officer 03/29/2022 48,474
Hoekman John Chief Scientific Officer 12/22/2021 32,800
NELSON TIMOTHY S Director 11/19/2021 107,554
SHREWSBURY STEPHEN B Chief Medical Officer 09/21/2021 199,720
ADAMS ADRIAN COB, CEO and President 08/18/2021 279,790
Vivo Capital VIII, LLC 10% Owner 04/27/2021 1,369,656
Vivo Capital VIII, LLC 10% Owner 04/27/2021 8,625,000
venBio Global Strategic Fund II L.P. 10% Owner 04/27/2021 6,750,000
PARKER H STEWART Director 04/27/2021 3,659
KKR Iris Investors LLC 10% Owner 04/27/2021 1,602,612
KKR Iris Investors LLC 10% Owner 04/27/2021 16,500,000
Load More Insider Transactions